Drug Shortage Report for MAR-RANITIDINE
Report ID | 103929 |
Drug Identification Number | 02443716 |
Brand name | MAR-RANITIDINE |
Common or Proper name | RANITIDINE |
Company Name | MARCAN PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | RANITIDINE |
Strength(s) | 300MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | A02BA |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Other (Please describe in comments) |
Anticipated start date | 2020-01-22 |
Actual start date | 2020-01-22 |
Estimated end date | 2020-08-11 |
Actual end date | 2020-08-10 |
Shortage status | Resolved |
Updated date | 2020-08-11 |
Company comments | Delay in the manufacturing process |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v13 | 2020-08-11 | English | Compare |
v12 | 2020-08-10 | French | Compare |
v11 | 2020-08-10 | English | Compare |
v10 | 2020-08-07 | French | Compare |
v9 | 2020-08-07 | English | Compare |
v8 | 2020-08-05 | French | Compare |
v7 | 2020-08-05 | English | Compare |
v6 | 2020-05-19 | French | Compare |
v5 | 2020-05-19 | English | Compare |
v4 | 2020-01-23 | English | Compare |
v3 | 2020-01-22 | French | Compare |
v2 | 2020-01-22 | English | Compare |
v1 | 2020-01-22 | English | Compare |
Showing 1 to 13 of 13